{"transactions":[{"id":4249450,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":174177,"kind":"organization","name":"Avalon Ventures VII L P","position":1,"cik":"0001318999","reported_name":"Avalon Ventures VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174178,"kind":"organization","name":"AVALON VENTURES VII GP, LLC","position":2,"cik":"0001380392","reported_name":"AVALON VENTURES VII GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":174179,"kind":"person","name":"Kinsella Kevin J","position":3,"cik":"0001311643","reported_name":"Kinsella Kevin J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":174180,"kind":"person","name":"Tomlin Stephen Lawrence","position":4,"cik":"0001695652","reported_name":"Tomlin Stephen Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2017-07-28T15:52:47.000Z","date":"2017-07-26","kind":"sale","acquired":false,"shares":37040,"price":24.35,"value":901924.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents the open-market sale by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of the Common Stock received as a result of the in-kind distribution described in footnote 1."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-019280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695652/000089924317019280/doc4.xml","form_type":"4"}},{"id":4249449,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":174177,"kind":"organization","name":"Avalon Ventures VII L P","position":1,"cik":"0001318999","reported_name":"Avalon Ventures VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174178,"kind":"organization","name":"AVALON VENTURES VII GP, LLC","position":2,"cik":"0001380392","reported_name":"AVALON VENTURES VII GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":174179,"kind":"person","name":"Kinsella Kevin J","position":3,"cik":"0001311643","reported_name":"Kinsella Kevin J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":174180,"kind":"person","name":"Tomlin Stephen Lawrence","position":4,"cik":"0001695652","reported_name":"Tomlin Stephen Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2017-07-28T15:52:47.000Z","date":"2017-07-26","kind":"other","acquired":true,"shares":37040,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents the receipt by Avalon Ventures VII GP, LLC, the general partner of Avalon Ventures VII, L.P., of its pro-rata portion of the in-kind distribution described in footnote 1."}],"balance_after":37040,"source":{"system":"sec-edgar","filing":"0000899243-17-019280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695652/000089924317019280/doc4.xml","form_type":"4"}},{"id":4249448,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":174177,"kind":"organization","name":"Avalon Ventures VII L P","position":1,"cik":"0001318999","reported_name":"Avalon Ventures VII L P","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":174178,"kind":"organization","name":"AVALON VENTURES VII GP, LLC","position":2,"cik":"0001380392","reported_name":"AVALON VENTURES VII GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":174179,"kind":"person","name":"Kinsella Kevin J","position":3,"cik":"0001311643","reported_name":"Kinsella Kevin J","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}},{"id":174180,"kind":"person","name":"Tomlin Stephen Lawrence","position":4,"cik":"0001695652","reported_name":"Tomlin Stephen Lawrence","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"See Remarks"}}],"security":"Common Stock","published_at":"2017-07-28T15:52:47.000Z","date":"2017-07-26","kind":"other","acquired":false,"shares":399987,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a pro-rata in-kind distribution of Common Stock by Avalon Ventures VII, L.P. effected on July 26, 2017 without consideration to its limited partners and to its general partner, Avalon Ventures VII GP, LLC."}],"balance_after":1636945,"source":{"system":"sec-edgar","filing":"0000899243-17-019280","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695652/000089924317019280/doc4.xml","form_type":"4"}}]}